Invivoscribe Begins Commercial Shipments of PrepQuant Systems for MRD Testing

Invivoscribe has started commercial shipments of its PrepQuant systems, which provide high-sensitivity sample preparation capabilities for minimal residual disease (MRD) testing in oncology.

2 Sept, 20:07 — 2 Sept, 20:07

Post Share

Sources

Showing 1 of 1 sources

morningstar3h ago

Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing - Morningstar

Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing Morningstar

Read full article →

Invivoscribe Begins Commercial Shipments of PrepQuant Systems for MRD Testing

Sources

Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing - Morningstar

Related Stories

Uber and Wayve Launch Robotaxi Service in London

NetApp and Broadcom Shares Fall Despite Beating Earnings Estimates

DOJ Expands Beef Price Antitrust Probe to Major Retailers

Uber Announces Global Layoffs and Exits Nigerian, Ugandan Markets